Leef Brands (LEEEF) Payables (2023 - 2026)

Leef Brands (LEEEF) posted Payables of $6.1 million for Q1 2026, up 5.28% sequentially from $5.8 million in Q4 2025.

Leef Brands (LEEEF) Payables (2023 - 2026) Analysis & Trends

Leef Brands has reported Payables for 4 years, with the latest figure at $6.1 million in Q1 2026.

Quarterly Payables changed N/A year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (changed N/A YoY) and the FY2025 annual result came in at $5.8 million, down 27.43% from the prior year.
Payables climbed to $6.1 million in Q1 2026 per LEEEF's latest filing, from $5.8 million in the prior quarter.
Over five years, Payables peaked at $8.0 million in Q4 2024 and troughed at $5.8 million in Q4 2025.
A 4-year average of $6.7 million and a median of $6.5 million in 2023 frame the typical range for Payables.
The sharpest annual moves came in 2024 and 2025: Payables advanced 13.82% in 2024, then declined 27.43% in 2025.
Over 4 years, Payables stood at $7.0 million in 2023, then climbed by 13.82% to $8.0 million in 2024, then slipped by 27.43% to $5.8 million in 2025, then gained by 5.28% to $6.1 million in 2026.
According to Business Quant data, Payables over the past three periods registered $6.1 million, $5.8 million, and $8.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-7.73 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	2.72 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	673.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	2.80 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	497.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	1.73 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	808.30 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	427.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	986.00 Mn
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn	6.28 Mn

Download Data